Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy Stifel Nicolaus

Cytokinetics Inc.
Start price
€40.80
02.09.25 / 50%
Target price
€82.03
02.09.26
Performance (%)
61.18%
Price
€65.76
18.08.26
Summary
This prediction is currently active. With a performance of 61.18% the BUY prediction by Stifel_Nicolaus is a big success. This prediction currently runs until 02.09.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cytokinetics Inc. -0.755% -0.755%
iShares Core DAX® -0,87 % 5,32 %
iShares Nasdaq 100 -0,38 % 1,98 %
iShares Nikkei 225® -1,68 % 1,95 %
iShares S&P 500 -0,65 % 2,07 %

Comments by Stifel_Nicolaus for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) 61.18%
Target price 82.032
Change
Ends at 02.09.26

Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Stifel Nicolaus from $87.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat

Stifel Nicolaus 
0
Report Share
02.09.25

Stopped prediction by Stifel_Nicolaus for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€45.00
22.01.25
€76.65
22.01.26
22.22%
23.01.26

Stifel Nicolaus 
22.01.25 50%